Compare Era Mandiri Cemerlang Tbk. (IKAN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Era Mandiri Cemerlang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp84 (market cap 70.83B, 22.67M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.4× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (22.67M versus 71K). Which is the better fit depends on your goals.
| IKAN | OBAT | |
|---|---|---|
Market Cap | 70.83B | 167.37B |
Volume | 22.67M | 71K |
Lot | 226.74K | 710 |
Turnover | 1.96B | 17.51M |
Average Price | 86.4 | 246.63 |
Value | 1.96B | 17.51M |
Indicative Equilibrium Price | 84 | 246 |
Indicative Equilibrium Volume | 6.44K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Era Mandiri Cemerlang Tbk.
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
